CIMETIDINE REDUCTION OF TUMOUR FORMATION IN MICE
- 1 March 1981
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 317 (8221) , 638-640
- https://doi.org/10.1016/s0140-6736(81)91555-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF)Cellular Immunology, 1980
- CIMETIDINE-INDUCED AUGMENTATION OF HUMAN LYMPHOCYTE BLASTOGENESIS BY MITOGEN, BACTERIAL ANTIGEN, AND ALLOANTIGENTransplantation, 1980
- Generation of Suppressor Lymphocytes During Sensitization in Culture against a Syngeneic Tumor: Affinity Chromatography on Insolubilized HistamineThe Journal of Immunology, 1978
- Pharmacological evaluation of cimetidine, a new histamine H2‐receptor antagonist, in healthy man.British Journal of Clinical Pharmacology, 1975
- Enhancing T lymphocytes from tumor‐bearing mice suppress host resistance to a syngeneic tumorEuropean Journal of Immunology, 1974
- Studies on the Mechanism of Lymphocyte-Mediated CytolysisThe Journal of Immunology, 1973
- REGULATION OF ANTIBODY RESPONSE BY CELLS EXPRESSING HISTAMINE RECEPTORSThe Journal of Experimental Medicine, 1972